Clathrin assembly regulation of glucose metabolism
Clathrin assembly regulation of glucose metabolism
批准号:
BB/V001221/1
负责人:
Frances Martha Brodsky
金额:
$66.33万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Organs and tissues are made up of cells that must be able to respond to their environment in order to carry out many tasks, including regulating growth, fighting infection and controlling nutrition. A critical step in nutritional regulation is the ability to maintain blood sugar levels after eating. The body does this by moving a protein called GLUT4 in fat and muscle cells from within the cell to the cell's surface in response to insulin, which is released when blood sugar levels are high. GLUT4 acts to shuttle glucose (the form of sugar in the blood) into the cell, thereby reducing blood sugar levels. As such, in a fasting state, GLUT4 is retained inside the cell to prevent blood sugar levels becoming dangerously low, but is moved to the cell surface in response to the insulin released after you eat to prevent blood sugar levels becoming dangerously high. The GLUT4 is then moved back inside the cell when blood sugar levels have returned to normal. Disruption of this ability to control blood sugar levels can lead to diabetes. Key to controlling blood sugar levels, therefore, is the ability to move GLUT4 from its specialised storage site to the cell surface in response to insulin, and then remove it from the cell surface after enough glucose has been removed from the blood. For this, a protein called clathrin is critical. Named for its clathrate (lattice-like) structure, clathrin acts to ensure that a huge range of proteins are in the right place in the cell at any time. Multiple molecules of clathrin self-assemble into basket-like coats that form and wrap around 'vesicles' that pinch off from membranes and are then transported to another part of the cell, in a mechanism known as 'membrane trafficking'. There are two forms of clathrin. The originally discovered form, referred to as CHC17, is best known for a stage in membrane traffic called 'endocytosis', the process by which proteins are moved from the cell surface to the interior of the cell. More recently, a second form of clathrin, CHC22, has been identified and been shown to be involved in a separate process. Instead of functioning at the cell surface, CHC22 operates entirely within the cell to move GLUT4 to its storage compartment, from where it is able to respond to insulin. Therefore, both forms of clathrin are critical to ensure that GLUT4 is trafficked properly in response to changing blood sugar levels. Recently, it has been discovered that humans have evolved two different forms of CHC22, and these two variants change how individuals are able to respond to blood glucose levels.A key step in understanding clathrin function is to understand how clathrin self-assembles into coats. Here, two laboratories that have studied clathrin biology for many years are joined by two other experts in analysing the structures and interactions of proteins to answer this question. Thanks to exciting recent advances in the structural knowledge of clathrin led by one of the investigators collaborating here, detailed structures of CHC17 assemblies, including many key interacting points, are now known for the first time. This work aims to build on this knowledge to compare the contacts that are critical to assemblies of CHC17 and CHC22, and test how these contact points affect assembly rates of both clathrins. The structure of CHC22 assemblies is less well known than that of CHC17. This work aims to rectify that, and will determine the structures of the two major CHC22 variants. We will use this information to investigate how the regulation of clathrin assembly affects GLUT4 trafficking in response to insulin in cells. Therefore, this work will help to understand the mechanisms by which clathrin functions, which could in turn aid in the development of therapeutic strategies to help alter blood glucose clearance, for instance in diabetic patients.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
CHC22 clathrin membrane recruitment uses SNX5 in bipartite interaction with secretory tether p115
CHC22 网格蛋白膜募集使用 SNX5 与分泌系链 p115 进行双向相互作用
DOI:
10.1101/2022.12.21.520923
发表时间:
2022
期刊:
影响因子:
--
作者:
[Greig J]
通讯作者:
Greig J
Formation and regulation of the human insulin-responsive intracellular GLUT4 transport pathway
-
批准号:MR/X018377/1
-
项目类别:Research Grant
-
资助金额:$83.27万
-
财政年份:2023
-
负责人:Frances Martha Brodsky
-
依托单位:
REGULATION OF HUMAN GLUCOSE HOMEOSTASIS BY THE NOVEL CHC22 CLATHRIN ISOFORM
-
批准号:MR/S008144/1
-
项目类别:Research Grant
-
资助金额:$74.22万
-
财政年份:2019
-
负责人:Frances Martha Brodsky
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ENKD1在纺锤体定向中的作用及分子机制
-
批准号:32000490
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:孙爽
-
依托单位:
果蝇纤毛细胞中特化细胞骨架的结构及其建立的分子基础解析
-
批准号:32070704
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:梁鑫
-
依托单位:
植物基因重组频率的遗传调控
-
批准号:31930018
-
项目类别:重点项目
-
资助金额:300.0万元
-
批准年份:2019
-
负责人:程祝宽
-
依托单位:
肌球蛋白18B通过影响微丝应力纤维组装调控肿瘤细胞迁移的机制研究
-
批准号:31970660
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:酒亚明
-
依托单位:
晶态桥联聚倍半硅氧烷的自导向组装(self-directed assembly)及其发光性能
-
批准号:21171046
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:李焕荣
-
依托单位:
嵌段共聚物多级自组装的多尺度模拟
-
批准号:20974040
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2009
-
负责人:吕中元
-
依托单位:
"锁住"的金属中心手性-手性笼络合物的动态CD光谱研究与应用开发
-
批准号:20973136
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2009
-
负责人:章慧
-
依托单位:
功能有机配体新颖设计与有机金属超分子导向组装
-
批准号:20772152
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2007
-
负责人:于澍燕
-
依托单位: